Based on the proteomic assessment of FDX1 expression profiles in cancer cell lines, neuroblastoma, thyroid cancer, and kidney cancer were ranked as the top three cancers with the lowest expression (Supplementary Figure S1B). The gene discussed is FDX1; the disease is kidney cancer.